221
Views
32
CrossRef citations to date
0
Altmetric
News

Psychiatric and Substance Abuse Comorbidity among HIV Seropositive and HIV Seronegative Prisoners in Malaysia

, M.D., , B.A., , M.D., , M.D., , M.D. & , M.D.
Pages 31-38 | Published online: 08 Feb 2010

REFERENCES

  • Teplin LA. The prevalence of severe mental disorder among male urban jail detainees: Comparison with the Epidemiologic Catchment Area Program. Am J Public Health 1990; 80:663–669.
  • Diamond PM, Wang EW, Holzer CE, Thomas C, des Anges C. The prevalence of mental illness in prison. Adm Policy Ment Health 2001; 29:21–40.
  • Spaulding A, Stephenson B, Macalino G, Ruby W, Clarke JG, Flanigan TP. Human immunodeficiency virus in correctional facilities: A review. Clin Infect Dis 2002; 35:305–312.
  • Otto-Salaj LL, Stevenson LY. Influence of psychiatric diagnoses and symptoms on HIV risk behavior in adults with serious mental illness. AIDS Read 2001; 11:197–198.
  • Altice FL, Mostashari F, Selwyn PA, Checko PJ, Singh R, Tanguay S, Blanchette EA. Predictors of HIV infection among newly sentenced male prisoners. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 18:444–453.
  • Himelhoch S, McCarthy JF, Ganoczy D, Medoff D, Dixon LB, Blow FC. Understanding associations between serious mental illness and HIV among patients in the VA Health System. Psychiatr Serv 2007; 58:1165–1172.
  • Koutsilieri E, Scheller C, Sopper S, ter Meulen V, Riederer P. The pathogenesis of HIV-induced dementia. Mech Ageing Dev 2002; 123;1047–1053.
  • Kaul M, Lipton SA. Mechanisms of neuroimmunity and neurodegeneration associated with HIV-1 infection and AIDS. J Neuroimmune Pharmacol 2006,1:138–151.
  • Judd F, Komiti A, Chua P, Mijch A, Hoy J, Grech P, Nature of depression in patients with HIV/AIDS. Aust N Z J Psychiatry 2005; 39:826–832.
  • Rihs TA, Begley K, Smith DE, Sarangapany J, Callaghan A, Kelly M, Efavirenz and chronic neuropsychiatric symptoms: a cross-sectional case control study. HIV Med 2006; 7:544–548.
  • Teplin LA. Psychiatric and substance abuse disorders among male urban jail detainees. Am J Public Health 1994; 84:290–293.
  • Holmwood C, Marriott M, Humeniuk R. Substance use patterns in newly admitted male and female South Australian prisoners using the WHO-ASSIST (Alcohol, Smoking and Substance Involvement Screening Test). Int J Prison Health 2008; 4:198–207.
  • Buckley PF, Brown ES. Prevalence and consequences of dual diagnosis. J Clin Psychiatry 2006; 67:e01-e01.
  • Stoskopf CH, Kim YK, Glover SH. Dual diagnosis: HIV and mental illness, a population-based study. Community mental health journal 2001,37:469–479.
  • Piselli M, Elisei S, Murgia N, Quartesan R, Abram KM. Co-occurring psychiatric and substance use disorders among male detainees in Italy. Int J Law Psychiatry 2009; 32:101–107.
  • Baillargeon J, Binswanger IA, Penn JV, Williams BA, Murray OJ. Psychiatric disorders and repeat incarcerations: the revolving prison door. Am J Psychiatry 2009; 166;103–109.
  • Warner TD, Kramer JH. Closing the Revolving Door?: Substance Abuse Treatment as an Alternative to Traditional Sentencing for Drug-Dependent Offenders. Crim Justice Behav 2009; 36:89–109.
  • Mazlan M, Schottenfeld RS, Chawarski MC. New challenges and opportunities in managing substance abuse in Malaysia. Drug Alcohol Rev 2006; 25;473–478.
  • Malaysian Psychiatric Association, Drug Addiction. July 2006. Available at: http://www.psychiatry-malaysia.org/ Accessed September 1, 2009.
  • Walmsley R. World prison population list. 8th edition: International Centre for Prison Studies, King's College London; 2009.
  • Dolan K, Kite B, Black E, Aceijas C, Stimson GV, Reference Group on HIVAP, HIV in prison in low-income and middle-income countries. Lancet Infect Dis 2007; 7:32–41.
  • The United Nation General Assembly Special Session on HIV/AIDS (UNGASS). UNGASS Country Progress Report: Malaysia, Geneva, Switzerland. 2008.
  • Baillargeon J, Ducate S, Pulvino J, Bradshaw P, Murray O, Olvera R. The association of psychiatric disorders and HIV infection in the correctional setting. Ann Epidemiol 2003; 13;606–612.
  • Navia BA, Jordan BD, Price RW. The AIDS dementia complex: I. Clinical features. 1986, 19;517–524.
  • Loewenstein RJ, Sharfstein SS. Neuropsychiatric aspects of acquired immune deficiency syndrome. Int J Psychiatry Med 1983; 13;255–260.
  • Hinkin CH, Castellon SA, Atkinson JH, Goodkin K. Neuropsychiatric aspects of HIV infection among older adults. J Clin Epidemiol 2001; 54 Suppl 1:S44-S52.
  • Sewell DD. Schizophrenia and HIV. Schizophr Bull 1996; 22;465–473.
  • Cournos F, McKinnon K, Meyer-Bahlburg H, Guido JR, Meyer I. HIV risk activity among persons with severe mental illness: preliminary findings. Hosp Community Psychiatry 1993; 44:1104–1106.
  • Volavka J, Convit A, O’Donnell J, Douyon R, Evangelista C, Czobor P. Assessment of risk behaviors for HIV infection among psychiatric inpatients. Hosp Community Psychiatry 1992; 43:482–485.
  • Kelly JA, Murphy DA, Bahr GR, Brasfield TL, Davis DR, Hauth AC, AIDS/HIV risk behavior among the chronic mentally ill. Am J Psychiatry 1992; 149;886–889.
  • Assadi SM, Noroozian M, Pakravannejad M, Yahyazadeh O, Aghayan S, Shariat SV, Fazel S. Psychiatric morbidity among sentenced prisoners: prevalence study in Iran. Br J Psychiatry 2006; 188;159–164.
  • Holzemer WL, Corless IB, Nokes KM, Turner JG, Brown MA, Powell-Cope GM, Predictors of self-reported adherence in persons living with HIV disease. AIDS Patient Care STDS 1999; 13;185–197.
  • Ingersoll K. The impact of psychiatric symptoms, drug use, and medication regimen on non-adherence to HIV treatment. AIDS Care 2004; 16;199–211.
  • Bradizza CM, Stasiewicz PR, Paas ND. Relapse to alcohol and drug use among individuals diagnosed with co-occurring mental health and substance use disorders: a review. Clin Psychol Rev 2006; 26;162–178.
  • Agbahowe SA, Ohaeri JU, Ogunlesi AO, Osahon R. Prevalence of psychiatric morbidity among convicted inmates in a Nigerian prison community. East Afr Med J 1998; 75:19–26.
  • Bulten E, Nijman H, Van Der Staak C. Psychiatric disorders and personality characteristics of prisoners at regular prison wards. Int J Law Psychiatry 2009; 32:115–119.
  • Rounds-Bryant JL, Baker L. Substance dependence and level of treatment need among recently-incarcerated prisoners. Am J Drug Alcohol Abuse 2007; 33:557–561.
  • Choi P, Kavasery R, Desai MM, Govindasamy S, Kamarulzaman A, Altice FL. Prevalence and Correlates of Community Re-Entry Challenges Faced by HIV-Infected Male Prisoners in Malaysia. Int J STD AIDS 2010: In Press.
  • Lukasiewicz M, Blecha L, Falissard B, Neveu X, Benyamina A, Reynaud M, Gasquet I. Dual diagnosis: prevalence, risk factors, and relationship with suicide risk in a nationwide sample of French prisoners. 2009; 33:160–168.
  • Wallace C, Mullen PE, Burgess P. Criminal offending in schizophrenia over a 25-year period marked by deinstitutionalization and increasing prevalence of comorbid substance use disorders. Am J Psychiatry 2004; 161;716–727.
  • Elhaj O YE, Sakai HE. The prevalence of bipolar and comorbid disorders in the Ottowa County Jail. In: the 157th annual meeting of the American Psychiatric Association. New York, NY; May 3, 2004.
  • Douaihy AB, Stowell KR, Kohnen S, Stoklosa JB, Breitbart WS. Psychiatric aspects of comorbid HIV/AIDS and pain, Part 2. AIDS Read 2007; 17;350–352, 357–361.
  • Bruce RD, Altice FL. Clinical Care of the HIV-Infected Drug User. Infect Dis Clin North Am 2007; 21;149–179.
  • Douaihy AB, Stowell KR, Kohnen S, Stoklosa JB, Breitbart WS. Psychiatric aspects of comorbid HIV/AIDS and pain, Part 1. AIDS Read 2007; 17;310–314.
  • Pollack H, Khoshnood K, Altice F. Health care delivery strategies for criminal offenders. J Health Care Finance 1999; 26;63–77.
  • Maru DS, Basu S, Altice FL. HIV control efforts should directly address incarceration. The Lancet Infectious Diseases 2007; 7:568–569.
  • Mellins CA, Havens JF, McDonnell C, Lichtenstein C, Uldall K, Chesney M, Adherence to antiretroviral medications and medical care in HIV-infected adults diagnosed with mental and substance abuse disorders. AIDS Care 2009; 21;168–177.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.